GetTopicDetailResponse(id=2e8a9e7241a, topicName=阿利庫單抗, introduction=阿利庫單抗, content=null, image=null, comments=4, allHits=989, url=https://h5.medsci.cn/topic?id=97724, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=84868, tagList=[TagDto(tagId=84868, tagName=阿利庫單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2066162, encodeId=97a12066162d8, content=<a href='/topic/show?id=2e8a9e7241a' target=_blank style='color:#2F92EE;'>#阿利庫單抗#</a>, objectTitle=Circulation：PCSK9抑制劑阿利庫單抗對急性冠脈綜合征患者卒中風險的影響, objectType=article, longId=185077, objectId=c42a1850e7c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c42a1850e7c0, replyNumber=0, likeNumber=149, createdTime=2020-01-22, rootId=0, userName=小華子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c42a1850e7c0, moduleTitle=Circulation：PCSK9抑制劑阿利庫單抗對急性冠脈綜合征患者卒中風險的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c42a1850e7c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066161, encodeId=2f88206616197, content=<a href='/topic/show?id=2e8a9e7241a' target=_blank style='color:#2F92EE;'>#阿利庫單抗#</a>, objectTitle=Circulation：阿利庫單抗治療對急性冠脈綜合征后的心源性死亡風險的影響, objectType=article, longId=175186, objectId=084c1e51860a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=084c1e51860a, replyNumber=0, likeNumber=98, createdTime=2020-03-26, rootId=0, userName=小華子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=084c1e51860a, moduleTitle=Circulation：阿利庫單抗治療對急性冠脈綜合征后的心源性死亡風險的影響, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=084c1e51860a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066160, encodeId=33332066160e4, content=<a href='/topic/show?id=2e8a9e7241a' target=_blank style='color:#2F92EE;'>#阿利庫單抗#</a>, objectTitle=JACC：阿利庫單抗能減少急性冠脈綜合征患者不良事件的發(fā)生, objectType=article, longId=159183, objectId=ba8b15918361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8b15918361, replyNumber=0, likeNumber=81, createdTime=2019-03-08, rootId=0, userName=小華子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8b15918361, moduleTitle=JACC：阿利庫單抗能減少急性冠脈綜合征患者不良事件的發(fā)生, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ba8b15918361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2066159, encodeId=a310206615982, content=<a href='/topic/show?id=2e8a9e7241a' target=_blank style='color:#2F92EE;'>#阿利庫單抗#</a>, objectTitle=Diabetic Med：阿利庫單抗安全性如何？, objectType=article, longId=156900, objectId=db0b15690088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db0b15690088, replyNumber=0, likeNumber=72, createdTime=2019-06-14, rootId=0, userName=小華子, userId=2e772500094, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db0b15690088, moduleTitle=Diabetic Med：阿利庫單抗安全性如何？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=db0b15690088)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
